• SENSEX 82,771.56
    584.75 (+0.71%)
  • BANKNIFTY 56,756.00
    -196.75 (--0.35%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,332.10 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,482.00(%)
  • One 97
    1,090.00 1,063.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Ola Electric
    43.95 157.53(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Anthem Bioscienc
    765.00 752.50(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Paradeep Phosph.
    205.60 193.15(%)
  • I R F C
    136.90 209.10(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • St Bk of India
    825.00 895.30(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Tata Motors
    692.95 1,179.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fermenta Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 146.0
  • ISIN : INE225B01021
386.95 8 (1.99%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    386.00

  • Today’s High

    386.95

  • Open

    386.00

  • Perv Close

    379.40

  • 52W Low

    219.00

  • 52W High

    449.00

Key Indicators

  • P/E(TTM)

    16.85

  • Mar.Cap (₹Cr.)

    1,138.83

  • Div & Yield %

    0.64

  • Book Value(₹)

    129.14

  • Debt-Equity Ratio

    1.99

  • AGM Date

    22-Jul-2025

  • EPS

    22.97

  • P/E Ratio

    16.85

Financials Ratios

  • Debt-Equity Ratio

    0.59

  • Mar.Cap (₹Cr.)

    1,138.83

  • RONW (%)

    -5.82

  • ROCE (%)

    2.96

Score Board

  • Equity (₹ in Cr.)

    14.72

  • BV (₹)

    129.10

  • Sales( ₹ in Cr.)

    430.53

  • NP (in Cr.)

    71.70

  • NP Var(%)

    1027.0

  • Div%

    50.0

  • CPS (₹)

    32.20

  • EPS (₹)

    24.40

  • Traded Value (₹ in Lakhs)

    1,138.83

  • 52 Week High

    449.00

  • 52 Week Low

    219.00

  • Price BSE

    387.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,138.83

  • P/C Ratio

    12.00

  • P/E Ratio

    15.90

  • Price Vs.BV

    24.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 430.53 307.09 328.91 387.96 372.82 300.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 1.24
Net Sales 430.53 307.09 328.91 387.96 372.82 299.27
Other Income 11.68 8.15 8.46 7.53 6.62 12.31
Stock Adjustments 7.59 -13.86 -17.29 -7.65 15.88 20.79
Total Income 449.80 301.38 320.08 387.84 395.32 332.37
EXPENDITURE :            
Raw Materials 146.22 91.57 109.21 136.55 139.52 103.46
Power and Fuel Cost 27.23 19.78 18.24 20.35 14.23 12.74
Employee Cost 60.10 53.93 53.81 59.36 57.50 50.03
Other Manufacturing Expenses 57.00 50.29 44.12 43.65 36.06 27.85
Selling and Administration Expenses 39.08 34.46 38.73 38.16 37.25 47.28
Miscellaneous Expenses 7.74 14.87 68.12 5.42 9.41 8.25
Employee Benefit Expenses 60.10 53.93 53.81 59.36 57.50 50.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 337.37 264.90 332.23 303.50 293.96 249.61
Operating Profit 112.43 36.49 -12.14 84.35 101.36 82.75
Interest 14.84 17.40 21.35 18.11 19.10 20.27
Gross Profit 97.59 19.09 -33.49 66.24 82.26 62.48
Depreciation 23.17 23.70 24.49 23.67 19.03 14.94
Profit Before Tax 74.42 -4.61 -57.98 42.57 63.23 47.54
Current Tax 13.12 14.14 -0.97 7.41 11.26 3.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -6.32 0.00 0.00 4.92 0.00 -19.49
Reported Net Profit 67.62 -18.74 -57.00 30.24 51.97 63.67
Extraordinary Items -4.09 -11.01 -60.09 -0.02 -0.13 1.90
Adjusted Net Profit 71.71 -7.73 3.09 30.26 52.10 61.77
Adjustment below Net Profit -0.80 0.12 9.52 -0.24 -0.04 -6.22
P & L Balance brought forward 276.80 299.03 350.72 327.93 275.99 218.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.61 3.61 4.20 7.21 0.00 0.00
P & L Balance carried down 340.00 276.80 299.03 350.72 327.93 275.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 25.00 25.00 25.00 50.00 100.00
Dividend Per Share(Rs) 2.50 1.25 1.25 1.25 2.50 5.00
Earnings Per Share-Unit Curr 23.18 -6.49 -19.75 10.48 18.01 22.07
Earnings Per Share(Adj)-Unit Curr 23.18 -6.49 -19.75 10.48 18.01 22.07
Book Value 130.26 108.83 116.45 137.26 128.42 108.36
Book Value(Adj)-Unit Curr 130.26 108.83 116.45 137.26 128.42 108.36

Shareholding Pattern

  • Promoter Group

    64.09%

  • Public Share Holding

    35.02%

  • Custodian

    0.89%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 2,240,376 2,240,376.00 2,240,376 2,240,376
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,240,376 7.61 2,240,376 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,620,633 56.47 16,620,633 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,620,633 56.47 16,620,633 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 120 0.00 120 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,298 0.02 7,298 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,418 0.03 7,418 3
2] Non Institution
Bodies Corporate 567,630 1.93 567,030 107
Clearing Members 1,000 0.00 1,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 273,641 0.93 273,641 308
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 263,745 0.90 263,745 387
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,329,312 11.31 3,329,312 24
Individuals holding nominal share capital up to Rs. 1 lakh 5,612,790 19.07 5,393,467 12,079
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 46,800 0.16 46,800 1
Others 172,926 0.59 172,926 1
Sub Total 10,300,549 35.00 10,080,626 12,922
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 262,011 0.89 262,011 1
Total Shares held by Custodians and against which Depository Receipts have been issued 262,011 0.89 262,011 1
Grand Total ( A + B + C ) 29,430,987 100.00 29,211,064 12,930

Company Background

Fermenta Biotech LtdPharmaceuticals - Indian - Bulk Drugs

  • Fermenta Biotech Ltd
  • BSE Code : 146.0
  • ISIN : INE225B01021

  • Incorporation Year

    1951

  • Registered Office

    A-1501 DIL Complex Majiwada
    Ghodbunder Road Thane One, Thane (West),
    Maharashtra-400610

  • Telephone

    91-22-66230800/888

  • FAX

    91-22-67980899

  • Chairman

    Pradeep Manjunath Chandan

  • Managing Director

    Prashant Nagre

  • Company Secretary

    Srikant N Sharma

  • Auditor

    S R B C & Co LLP

  • Face Value

    5

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Fermenta Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fermenta Biotec. 386.95 442.21 430.53 16.85 17.61
Abbott India 34,192.50 6,684.73 6,409.15 51.37 44.95
Astrazeneca Phar 9,002.30 1,330.33 1,295.53 194.43 33.26
P & G Health Ltd 5,861.90 1,166.89 1,151.26 38.74 39.76
Glaxosmi. Pharma 3,098.40 3,866.05 3,723.49 57.11 58.72
Cipla 1,465.00 20,029.57 19,044.85 22.94 21.40
Novartis India 1,061.45 398.23 356.27 25.97 16.64
Amrutanjan Healt 699.55 437.58 421.23 39.79 20.84
Guj. Themis Bio. 372.80 174.19 169.82 83.21 44.82
Bliss GVS Pharma 158.55 703.42 667.20 24.24 9.16
Ambalal Sarabhai 35.11 19.33 4.04 32.51 2.10